Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran

Abstract Background No research has assessed the comprehensive annual costs of managing ulcerative colitis (UC) patients undergoing biological treatment. This study aimed to determine the annual costs and primary cost drivers for UC patients receiving biological therapy. Methods This prospective obs...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hassan Karami, Amin Ghanbarnejad, Mitra Nowrouzpour, Ali Mouseli, Reihaneh Taheri Kondar, Maryam Shirvani Shiri, Farbod Ebadi Fard Azar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-03-01
coleção:	BMC Health Services Research
Assuntos:	Ulcerative colitis Cost of illness Economic burden Direct costs Indirect costs
Acesso em linha:	https://doi.org/10.1186/s12913-025-12474-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!